In summary, our results have demonstrated that AnxA2 molecules interact with a TRAM-TRIF adaptor complex and subsequently regulate TLR4 endosomal signaling and its anti-inflammatory action during endotoxemia. The gene discussed is ANXA2; the disease is serum lipopolysaccharide activity.